NCT05669781

Brief Summary

A delay in the return of bowel function is a common occurrence after abdominal surgeries.1 The goal of this study was to test the effect of the combined use of chewing a gum and administering metoclopramide intravenously on the duration of this natural delay in the return of bowel function after abdominal surgeries. Patients were grouped into four: the first group received both gum and metoclopramide; the second group received only gum; the third group received only metoclopramide, while the fourth group (the control group) received sterile water for injection. The groups were compared for the time taken for bowel function to return and the duration of hospital stay.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Oct 2018

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

December 17, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 3, 2023

Completed
Last Updated

January 3, 2023

Status Verified

December 1, 2022

Enrollment Period

12 months

First QC Date

December 17, 2022

Last Update Submit

December 30, 2022

Conditions

Keywords

Gum-chewingMetoclopramideAbdominalSurgery

Outcome Measures

Primary Outcomes (1)

  • Duration of post-operative ileus

    Time to either the passage of flatus or feces, assessed every 8hours from post-operative day 1

    From 24 hours after surgery up to the time either flatus or feces is passed, for up to 1week after surgery

Secondary Outcomes (1)

  • Duration of hospital stay

    First post-operative day up to the day of discharge, for up to 25days after surgery

Study Arms (4)

Gum-Metoclopramide

ACTIVE COMPARATOR

Intravenous metoclopramide 10mg 8hourly for the first 72hours post-operatively and to chew one a stick of sugar free gum (to be chewed over 15minutes) 8 hourly till either first flatus or feces was passed

Combination Product: Gum and metoclopramide

Gum-only

ACTIVE COMPARATOR

Chew one stick of sugar free gum (to be chewed over 15minutes) 8 hourly till either first flatus or feces was passed

Other: Gum

Metoclopramide-only

ACTIVE COMPARATOR

Intravenous metoclopramide 10mg 8hourly for the first 72hours post-operatively

Drug: Metoclopramide 10mg

Control

PLACEBO COMPARATOR

10ml of sterile water intravenously 8hourly for the first 72hours post-operatively

Other: Control

Interventions

Intravenous metoclopramide 10mg 8hourly for the first 72hours post-operatively

Also known as: Philometro, Hubei Tianyao
Metoclopramide-only
Gum and metoclopramideCOMBINATION_PRODUCT

Intravenous metoclopramide 10mg 8hourly for the first 72hours post-operatively and one stick of sugar-free gum (over 15minutes) 8 hourly till either the first flatus or feces was passed

Gum-Metoclopramide
GumOTHER

One stick of sugar-free gum (over 15minutes) 8 hourly till either the first flatus or feces was passed

Gum-only
ControlOTHER

10ml of sterile water intravenously 8hourly for the first 72hours post-operatively

Control

Eligibility Criteria

Age16 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All patients requiring elective abdominal surgery aged 16-65years

You may not qualify if:

  • Abdominal emergency surgeries
  • Structural or functional inability to chew gum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College Hospital

Ibadan, Oyo State, +234, Nigeria

Location

Related Publications (3)

  • Pedziwiatr M, Kisialeuski M, Wierdak M, Stanek M, Natkaniec M, Matlok M, Major P, Malczak P, Budzynski A. Early implementation of Enhanced Recovery After Surgery (ERAS(R)) protocol - Compliance improves outcomes: A prospective cohort study. Int J Surg. 2015 Sep;21:75-81. doi: 10.1016/j.ijsu.2015.06.087. Epub 2015 Jul 29.

    PMID: 26231994BACKGROUND
  • COHEN J. The statistical power of abnormal-social psychological research: a review. J Abnorm Soc Psychol. 1962 Sep;65:145-53. doi: 10.1037/h0045186. No abstract available.

    PMID: 13880271BACKGROUND
  • Delaney C, Kehlet H, Senagore AJ, Bauer AJ, Beart R, Billingham R, et al. Postoperative ileus: profiles, risk factors, and definitions - a framework for optimizing surgical outcomes in patients undergoing major abdominal colorectal surgery. In: Bosker G, editor. Clinical consensus update in general surgery; 2006 May 1; Massachusetts United States. Roswell (GA): Pharmatecture, LLC; 2006. p. 1-26.

    BACKGROUND

MeSH Terms

Interventions

MetoclopramideChewing Gum

Intervention Hierarchy (Ancestors)

BenzamidesAmidesOrganic Chemicalspara-AminobenzoatesAminobenzoatesBenzoatesAcids, CarbocyclicCarboxylic AcidsChlorobenzoatesHydroxybenzoate EthersHydroxybenzoatesHydroxy AcidsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsPhenyl EthersPhenolsPlant GumsBiopolymersPolymersMacromolecular SubstancesPolysaccharidesCarbohydratesPlant ExudatesBiological ProductsComplex MixturesCandyFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Ikechukwu B. Ulasi

    University College Hospital, Ibadan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Model Details: Patients were randomized into a gum-metoclopramide (GM) group, a gum-only (G) group, a metoclopramide-only (M) group and a control (C) group. Patients in the GM group chewed gum and received intravenous metoclopramide, each 8 hourly. In the G group, patients chewed only gum while those in the M group received 10mg of intravenous metoclopramide only. To the C group, 10ml of intravenous sterile water for injection was given 8 hourly
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 17, 2022

First Posted

January 3, 2023

Study Start

October 1, 2018

Primary Completion

September 30, 2019

Study Completion

September 30, 2019

Last Updated

January 3, 2023

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations